Page last updated: 2024-11-04

temozolomide and Cancer of Cervix

temozolomide has been researched along with Cancer of Cervix in 2 studies

Research Excerpts

ExcerptRelevanceReference
"MCF-7 breast cancer cells expressing the α(v)β(3) [alpha(v)beta(3)] integrin receptor are considered as appropriate candidates for such a targeted therapy."1.36A cyclic-RGD-BioShuttle functionalized with TMZ by DARinv "Click Chemistry" targeted to αvβ3 integrin for therapy. ( Bäuerle, T; Braun, K; Ehemann, V; Fleischhacker, H; Lorenz, P; Müller, G; Pipkorn, R; Waldeck, W; Wiessler, M, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braun, K1
Wiessler, M1
Pipkorn, R1
Ehemann, V1
Bäuerle, T1
Fleischhacker, H1
Müller, G1
Lorenz, P1
Waldeck, W1
Paik, J1
Duncan, T1
Lindahl, T1
Sedgwick, B1

Other Studies

2 other studies available for temozolomide and Cancer of Cervix

ArticleYear
A cyclic-RGD-BioShuttle functionalized with TMZ by DARinv "Click Chemistry" targeted to αvβ3 integrin for therapy.
    International journal of medical sciences, 2010, Sep-21, Volume: 7, Issue:6

    Topics: Antineoplastic Agents, Alkylating; Breast Neoplasms; Cell Line, Tumor; Cell Size; Dacarbazine; Femal

2010
Sensitization of human carcinoma cells to alkylating agents by small interfering RNA suppression of 3-alkyladenine-DNA glycosylase.
    Cancer research, 2005, Nov-15, Volume: 65, Issue:22

    Topics: Antineoplastic Agents, Alkylating; Carmustine; Cell Cycle; Dacarbazine; DNA Glycosylases; Female; Ge

2005